SCHEMBL17359489

SCHEMBL17359489

CCC(C)C1OC(CO)C(O)C(OC2OC(C(=O)O)C(OC(C)(C)CC)C(O)C2O)C1NC(C)=O

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.42
▸ THRB P10828 1/20 0.42
▸ MAPK1 P28482 2/20 0.41
▸ LGALS3 P17931 5/20 0.40
▸ LGALS8 O00214 1/20 0.40
▸ LGALS4 P56470 1/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ MDK P21741 2/20 0.36
▸ BDNF P23560 2/20 0.36
▸ PTN P21246 1/20 0.36
▸ CD69 Q07108 1/20 0.35
▸ MAG P20916 1/20 0.35
▸ CHIA Q9BZP6 1/20 0.34
▸ FGF1 P05230 1/20 0.34
▸ LGALS1 P09382 1/20 0.34
▸ LGALS7; LGALS7B P47929 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22570748 0.88 ALDH1A1 (0.45) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL26473755 0.87 ALDH1A1 (0.47) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL18098580 0.87 ALDH1A1 (0.47) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL21650603 0.87 ALDH1A1 (0.47) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL21316636 0.87 ALDH1A1 (0.42) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL17742330 0.86 ALDH1A1 (0.53) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL19273575 0.86 LGALS3 (0.42) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL18737220 0.85 LGALS3 (0.42) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL19833209 0.84 ALDH1A1 (0.46) ALDH1A1THRBMAPK1LGALS3LGALS8
SCHEMBL18883210 0.84 ALDH1A1 (0.46) ALDH1A1THRBMAPK1LGALS3LGALS8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11673974-B2 Glycophospholipid polymeric network and use thereof BAUSCH & LOMB INCORPORATED (US) 2023-06-13 — — US disclosed
US-20200339710-A1 GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF BAUSCH HEALTH US, LLC 2020-10-29 — — US disclosed
US-20150366976-A1 INJECTABLE FILLER MIBA MEDICAL INC. (US) 2015-12-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150366976-A1 INJECTABLE FILLER CD44, MMP1, PLOD3 ALDH1A1 706/4885THRB 4307/4885MAPK1 4109/4885
US-11673974-B2 Glycophospholipid polymeric network and use thereof ALG1, CSGALNACT1, FUT5 ALDH1A1 3218/4885THRB 3418/4885MAPK1 3364/4885
US-20200339710-A1 GLYCOPHOSPHOLIPID POLYMERIC NETWORK AND USE THEREOF ALG1, CSGALNACT1, FUT5 ALDH1A1 3218/4885THRB 3418/4885MAPK1 3364/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback